Molbio Diagnostics Ltd vs Prevest Denpro Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Molbio Diagnostics Ltd is ₹ 1237 as of 23 Oct 15:30 . The P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Prevest Denpro Ltd changed from 26.3 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 6 years The Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Prevest Denpro Ltd changed from ₹ 423.77 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 6 years The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The revenue of Prevest Denpro Ltd for the Jun '26 is ₹ 20.38 crore as compare to the Mar '26 revenue of ₹ 20.35 crore. This represent the growth of 0.15% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The ebitda of Prevest Denpro Ltd for the Jun '26 is ₹ 8.08 crore as compare to the Mar '26 ebitda of ₹ 8.32 crore. This represent the decline of -2.88% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The net profit of Prevest Denpro Ltd changed from ₹ 3.67 crore to ₹ 5.64 crore over 9 quarters. This represents a CAGR of 21.04% The Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prevest Denpro Ltd changed from 7.64 % on March 2023 to 5.6 % on March 2026 . This represents a CAGR of -7.47% over 4 years .

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

About Prevest Denpro Ltd

Prevest Denpro Limited is one of the world's leading dental materials manufacturer, which was incorporated on May 05, 1999, with the Registrar of Companies, Jammu & Kashmir.
The Company is primarily involved in the manufacturing of Dental Preparations. The Company develop, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile.
The product offerings addresses majority of dentists' clinical needs for consumable dental materials.
The product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables.
The products are sold in over 75 countries in the regions of Europe, Asia, South America, Middle East and Africa.

FAQs for the comparison of null and Prevest Denpro Ltd

Which company has a larger market capitalization, Molbio Diagnostics Ltd or Prevest Denpro Ltd?

Market cap of Molbio Diagnostics Ltd is 14,262 Cr while Market cap of Prevest Denpro Ltd is 453 Cr

What are the key factors driving the stock performance of Molbio Diagnostics Ltd and Prevest Denpro Ltd?

The stock performance of Molbio Diagnostics Ltd and Prevest Denpro Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Molbio Diagnostics Ltd and Prevest Denpro Ltd?

As of October 25, 2026, the Molbio Diagnostics Ltd stock price is INR ₹1237.65. On the other hand, Prevest Denpro Ltd stock price is INR ₹377.55.

How do dividend payouts of Molbio Diagnostics Ltd and Prevest Denpro Ltd compare?

To compare the dividend payouts of Molbio Diagnostics Ltd and Prevest Denpro Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.